From The Stage

Large Molecule Sample Analysis for a Large Number of Samples: Why Veteran Expertise is Critical to Success

Posted by / / CRO Selection, Sample Analysis

When it comes to analyzing large numbers of samples, it is a common misconception that the quality of instrumentation and facility are enough to ensure accurate, consistent results. This may be true for analysis of small molecule drugs, which have simple, stable, well-defined structures and little ability to initiate immune responses. However, the characteristics of large molecule drugs are very different, with numerous intricacies that can impact bioanalytical results. Consider the disparity in levels of complexity alone: aspirin, a typical small molecule drug, has 21 atoms; whereas a large molecule…

CRO Communication: Responsiveness for Better Bioanalytical Results

Posted by / / BioAgilytix Insight, Bioanalytical Lab Quality, CRO Selection

Because of the inherent complexities of large molecule bioanalysis, open communication throughout every study is vital to success. Ideally, there should be a constant stream of information flowing between the customer and the lab conducting their research, in order to proactively identify pitfalls, address potential challenges, and overcome issues before they cause project delays or compromised results. However, sponsors today still lack confidence in traditional CROs’ ability to communicate actively and cooperatively, as evidenced by the 2015 Contract Pharma survey where 46% of respondents cited poor communication as the biggest…

In Bioanalysis, Timing is Everything: Can Your CRO Keep Up with Your Innovation Demands?

Posted by / / BioAgilytix Insight, Bioanalytical Lab Quality, CRO Selection

A 2015 survey from ISR Reports found that among the top metrics evaluated by sponsors when selecting a bioanalytical lab partner were turnaround time and on-time data and report delivery. This is logical in today’s fast-paced world of pharma and biotech innovation, where missed deadlines and timeline creep can not only compromise a competitive advantage, but delay the release of life-saving biologics to the market. And while a 2016 NiceInsight survey found that 50% of sponsor respondents said they would actually switch CROs based on lack of on-time delivery, the…

Where Expertise and Quality Converge: For CROs, One Isn’t Optimized without the Other

Posted by / / BioAgilytix Insight, Bioanalytical Lab Quality, CRO Selection

When pharma and biotech organizations look to work with a CRO or bioanalytical lab, quality is always among the top priorities. In fact, a recent Nice Insight survey on outsourcing trends in 2016 found that 70% of respondents agreed that quality is the most important driver when selecting a CRO to partner with. But quality is not a single checkbox on the list of factors for CRO selection; rather, it is the collection of all attributes and capabilities that the CRO brings to the table, which enable quality to permeate…

BioAgilytix Innovates and Grows in the ‘National Innovation Triangle’

Posted by / / BioAgilytix Insight, CRO Selection

When people hear the word innovation, they most often think of Silicon Valley or the Boston-New York corridor—but as a recent Newsweek Elite Reports article featuring BioAgilytix finds, North Carolina is rising quickly to the forefront of such conversations as the third pillar of the ‘National Innovation Triangle’. In fact, the U.S. Department of Commerce’s Bureau of Economic Analysis found North Carolina to have the nation’s fastest growing economy between Q1 2013 and Q1 2015. Much of this is due to the pharmaceutical and biotech R&D happening in and around…

Taking the Stage on Bioanalytical Topics – Looking Back & Looking Ahead

Posted by / / BioAgilytix Insight, Biomarkers, CRO Selection

Welcome to BioAgilytix’s new blog, which gives you the chance to tap the expertise and insights of our talented team on a regular basis. This forum gives us a new way to share firsthand scientific perspectives on everything from overarching bioanalytical industry trends to specific assay challenges, platform uses, case studies, and more.Like our Virtual Podium series – in which we engage industry thought leaders to share their expertise, experiences, and advice via timely, on-demand video segments – we hope that this blog will also become a valuable resource for…